Product: Le Cru du Clocher raw milk cheddar cheese
Companies: Le Fromage au Village Inc.
Issue: Food ? Microbial contamination ? Listeria
Category: Dairy
What to do: Do not consume, use, sell, serve, or distribute recalled products
Audience: General public
Recall class: Class 1
Affected products
Brand
Product
Size
UPC
Codes
Le Fromage au Village
Le Cru du Clocher raw milk cheddar cheese
160 g
6 73536 00051 8
B98
All Best Before dates
Le Fromage au Village
Le Cru du Clocher raw milk cheddar cheese
variable
none
B98
All Best Before dates
Issue
The affected products are being recalled from the marketplace due to possible Listeria contamination.
The recalled products have been sold in Ontario, Quebec, online and may have been distributed in other provinces and territories.
What you should do
If you think you became sick from consuming a recalled product, contact your healthcare provider
Check to see if you have recalled products
Do not consume, serve, use, sell, or distribute recalled products
Recalled products should be thrown out or returned to the location where they were purchased
Food contaminated with Listeria monocytogenes may not look or smell spoiled but can still make you sick. Symptoms can include vomiting, nausea, persistent fever, muscle aches, severe headache and neck stiffness. Pregnant women, the elderly and people with weakened immune systems are particularly at risk. Although infected pregnant women may experience only mild, flu-like symptoms, the infection can lead to premature delivery, infection of the newborn or even stillbirth. In severe cases of illness, people may die.
Masimo today announced that its management will participate in the BofA Securities Health Care Conference on Wednesday, May 15, 2024 at 4:20 p.m. Pacific Time. A live webcast of the presentation will be available on the Masimo website at...
This week, Epione will celebrate another milestone at a leading cancer institute where the 100th patient will be treated using the technology. Epione, a robotic- assisted platform used in interventional oncology, is designed to support physicians...
CEL-SCI Corporation today announced a significantly positive outcome from its recent meeting with the U.S. Food and Drug Administration (FDA) regarding the path to approval for its first-line investigational cancer immunotherapy Multikine*...
Dr. Vince Clinical Research (DVCR), a full-service contract research organization (CRO), today announced the appointment of Sheldon Preskorn, M.D., as its Senior Vice President of Neuroscience. Dr. Preskorn is a world-renowned researcher, academic...
Amylyx Pharmaceuticals, Inc. ("Amylyx" or the "Company") today announced that Joshua Cohen and Justin Klee, Co-CEOs of Amylyx, and Camille L. Bedrosian, MD, Chief Medical Officer of Amylyx, will participate in the 2024 Bank of America Health Care...
Today, Everest Rehabilitation Hospitals announced plans to construct a 40-bed inpatient physical rehabilitation hospital in N.E. San Antonio, specifically in Live Oak, Texas will be Everest's third location in the San Antonio Metroplex.
We believe...